Marijuana legalization reduces opioid deaths
A new Economic Inquiry study finds that marijuana access leads to reductions in opioid-related deaths.
Aug 7, 2019
0
152
A new Economic Inquiry study finds that marijuana access leads to reductions in opioid-related deaths.
Aug 7, 2019
0
152
Louisiana is becoming the first Deep South state to dispense medical marijuana on Tuesday, four years after state lawmakers agreed to give patients access to therapeutic cannabis.
Aug 6, 2019
0
3
Medical marijuana is expected to start reaching select dispensaries in Louisiana on Tuesday, after the state agriculture department completed final testing and cleared therapeutic cannabis for release to patients.
Aug 2, 2019
0
1
(HealthDay)—Some proponents of medical marijuana have claimed that its use against pain might help curb the ongoing crisis of opioid abuse.
Jul 17, 2019
1
2
A Florida appellate court ruled that the state's approach to regulating marijuana is unconstitutional, possibly allowing more providers to jump into a market positioned to become one of the country's most lucrative.
Jul 10, 2019
0
0
New research suggests legalizing recreational marijuana for U.S. adults in some states may have slightly reduced teens' odds of using pot.
Jul 8, 2019
0
0
New Jersey expanded its medical marijuana program, including increasing the number of illnesses eligible for cannabis use, under a broad new law signed by the governor Tuesday.
Jul 2, 2019
0
0
It's been called the Italian "green gold rush." Mild, barely there marijuana dubbed "cannabis light" has put Italy on the international weed map, producing hundreds of stores that sell pot by the pouch and attention from ...
Jun 27, 2019
0
0
A group of French economists on Thursday recommended legalising marijuana, arguing it would add billions to state coffers, but President Emmanuel Macron's government again ruled out letting recreational users get legally ...
Jun 20, 2019
0
0
Young adults who live in neighborhoods with more medical marijuana dispensaries use marijuana more frequently than their peers and have more-positive views about the drug, according to a new RAND Corporation study.
Jun 17, 2019
0
1